Spencer Laird is the second patient at Duke Cancer Clinic to undergo immunotherapy treatment for stage 4 colon cancer ...

T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...

Scientists at UC San Diego and Sanford Burnham Prebys say combining drugs that inhibit a problem protein with immunotherapy ...

A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This ...

A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July ...

Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for ...

The field of cancer immunology has seen significant advancements in recent years, particularly with the emergence of immunotherapy as a key pillar in the ...

Perioperative immunotherapy — administered before surgery, within the perioperative window, or after resection — is rapidly becoming a treatment paradigm ...

The phase 3 ATOMIC trial is changing the way we treat stage III dMMR colon cancer. In this video, Dr. Sinicrope breaks down ...

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), th cancer immunotherapy developer, has named David Schilansky as ...